Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

HSI June 2026 Index Rebalance: Post-Implementation Review

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

Zijin Gold International / Index Rebalance

<ul>
<li>We review the HSLMI universe for potential candidates for the upcoming HSI August 2026 review.</li>
<li>Three stocks stand out as ADD candidates this cycle, one of them high conviction.</li>
<li>We also highlight substantial FF and weight changes for CATL.</li>
</ul>


We review the HSLMI universe for potential candidates for the upcoming HSI August 2026 review.
Three stocks stand out as ADD candidates this cycle, one of them high conviction.
We also highlight substantial FF and weight changes for CATL.


China Resources Mixc Lifestyle Services (1209 HK)

Contemporary Amperex Technology (3750 HK)

Zijin Gold International

HSI Sep 2026 Index Rebalance Forecast